We are live on ! Find out more
CASI

CASI Pharmaceuticals
CASI

Delisted

CASI was delisted on the 25th of February, 2026.

Back to rankings

26 hedge funds and large institutions have $6.64M invested in CASI Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

CASI Hedge Fund Activity: Q2 2013 in Review

26 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in CASI Pharmaceuticals (CASI) for Q2 2013, worth a combined $6.64M.

Buyers outnumbered sellers: 26 funds opened new CASI positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

  • 26 institutional investors held CASI Pharmaceuticals (CASI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $6.64M of CASI Pharmaceuticals stock for Q2 2013.
  • 26 funds opened new CASI Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +26 holders.

Based on aggregated 13F filings for Q2 2013.